Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma

Clinical trial NCT00098865 · COMPLETED

Trial details

NCT number: NCT00098865
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Central Nervous System Tumor, Pediatric Neuroblastoma

Start date: 2002-09-01
Primary completion: 2010-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.